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Tissue engineering with gellan gum 
Abstract 
Engineering complex tissues for research and clinical applications relies on high-performance 
biomaterials that are amenable to biofabrication, maintain mechanical integrity, support specific cell 
behaviours, and, ultimately, biodegrade. In most cases, complex tissues will need to be fabricated from 
not one, but many biomaterials, which collectively fulfill these demanding requirements. Gellan gum is an 
anionic polysaccharide with potential to fill several key roles in engineered tissues, particularly after 
modification and blending. This review focuses on the present state of research into gellan gum, from its 
origins, purification and modification, through processing and biofabrication options, to its performance 
as a cell scaffold for both soft tissue and load bearing applications. Overall, we find gellan gum to be a 
highly versatile backbone material for tissue engineering research, upon which a broad array of form and 
functionality can be built. 
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Tissue	Engineering	with	Gellan	Gum	
L.	R.	Stevens,	a	K.	J.	Gilmore,	a	G.	G.	Wallace	a	and	M.	in	het	Panhuis	a.b	
Engineering	 complex	 tissues	 for	 research	 and	 clinical	 applications	 relies	 on	 high-performance	 biomaterials	 that	 are	
amenable	to	biofabrication,	maintain	mechanical	integrity,	support	specific	cell	behaviours,	and,	ultimately,	biodegrade.	In	
most	cases,	complex	tissues	will	need	to	be	fabricated	from	not	one,	but	many	biomaterials,	which	collectively	fulfill	these	
demanding	 requirements.	Gellan	 gum	 is	 an	 anionic	 polysaccharide	with	potential	 to	 fill	 several	 key	 roles	 in	 engineered	
tissues,	particularly	after	modification	and	blending.	This	review	focuses	on	the	present	state	of	research	into	gellan	gum,	
from	its	origins,	purification	and	modification,	through	processing	and	biofabrication	options,	to	its	performance	as	a	cell	
scaffold	for	both	soft	tissue	and	load	bearing	applications.	Overall,	we	find	gellan	gum	to	be	a	highly	versatile	backbone	
material	for	tissue	engineering	research,	upon	which	a	broad	array	of	form	and	functionality	can	be	built.			
Introduction:	The	Tissue	Engineering	Imperative	
Tissue	 engineering	 (TE)	 is	 a	 field	 of	 research	 that	 aims	 to	
combine	cells	and	biomaterials	 into	 functional	structures	 that	
have	the	potential	to	repair,	replace	or	replicate	living	tissues.	
The	 field	 has	 progressed	markedly	 over	 recent	 decades,	 and	
stands	poised	to	provide	viable	clinical	therapies	for	the	repair	
of	 skin1,	 cartilage2,	 3,	 bladder4,	 5,	 vasculature6	 and	 bone7.	
Research	 is	 increasingly	being	 focused	on	the	regeneration	of	
‘complex’	 tissues	with	multi-layered,	multi-cellular	 and	highly	
vascularised	 structures8.	 The	 scientific	 advances	 that	 are	
required	 to	 progress	 the	 field	 of	 TE	 towards	 complex	 tissue	
fabrication	have	been	regularly	reviewed9-11,	with	biomaterials	
design12-14	 and	 processing15-18	 being	 frequently	 highlighted	 as	
areas	of	priority.	
 
The	primary	function	of	biomaterials	in	TE	is	the	encapsulation	
and	 support	 of	 living	 cells.	 For	 this	 reason,	 many	 of	 the	
materials	utilised	in	TE	are	either	sourced	from,	or	functionally	
replicate,	 those	 present	 in	 the	 natural	 extracellular	 matrix	
(ECM)19.	 The	 ECM	 is	 a	 complex	 network	 of	 proteins	 and	
polysaccharides	 that	 surrounds	 and	 supports	 living	 tissues	
(Figure	 1).	 As	well	 as	 providing	mechanical	 support,	many	 of	
these	ECM	components	also	play	critical	roles	in	cell	signalling	
and	cell	adhesion	processes	that	modulate	cell	behaviour20.	To	
ensure	artificial	scaffolds	provide	an	effective	platform	for	TE,	
it	 is	 critical	 that	 they	 replicate	 both	 the	 structural	 and	
functional	roles	exhibited	by	the	natural	ECM21,	22.	Additionally,	
TE	 biomaterials	 must	 be	 biocompatible,	 and	 induce	 minimal	
immunogenic	 or	 fibrotic	 response	 upon	 implantation23,	 24.	
Unlike	 inert	 implants,	 biomaterials	 are	 also	 expected	 to	
controllably	 biodegrade	 such	 that	 the	 engineered	 scaffold	
progressively	 gives	 way	 to	 natural	 ECM	 components	 as	 the	
recovering	 tissue	 repairs	 and	 remodels	 its	 surroundings24.	
Finally,	biomaterials	for	TE	need	to	be	processable.	This	broad	
term	is	determined	by	a	number	of	specific	material	properties	
including	viscosity,	 surface	 tension,	 cross-linking	mechanisms,	
pH	 and	 phase	 transition	 temperatures.	 All	 such	 properties	
must	fall	within	certain	tolerable	ranges	for	the	material	to	be	
reliably	 processed	 using	 the	 emerging	 suite	 of	 biofabrication	
technologies	 14.	 Ideally,	 the	 materials	 employed	 in	 TE	 would	
possess	all	of	these	favourable	characteristics,	rendering	them	
processable,	mechanically	robust,	biocompatible,	biofunctional	
and	biodegradable.	Realistically,	this	array	of	requirements	will	
require	 a	 broad	 spectrum	 of	 materials	 that	 work	 in	 concert	
within	 the	 engineered	 tissue.	 One	 class	 of	 biomaterials	 with	
significant	 potential	 to	 contribute	 to	 engineered	 tissues	 are	
the	 polysaccharides,	 of	 which	 several	 are	 known	 to	 be	 both	
processable	and	biocompatible.	Reviews	that	directly	compare	
the	various	polysaccharides	used	in	TE	have	been	published	by	
Khan	 and	 Ahmad25,	 as	 well	 as	 Bacáková	 et	 al.26.	 This	 review	
focuses	 on	 gellan	 gum,	 an	 emerging	 polysaccharide	 with	
potential	 as	 a	 versatile	 and	 processable	 scaffold	 material	
suitable	for	a	broad	range	of	engineered	tissues.		
	
Figure	1:	The	Extracellular	Matrix:	The	natural	ECM	is	a	complex	and	multi-component	
system	containing	collagen,	elastin,	proteoglycans,	polysaccharides	and	glycoproteins.	
Collectively	 these	elements	provide	mechanical	 integrity,	cell	adhesion	and	signalling,	
roles	that	must	be	replicated	in	synthetic	extracellular	matrix	mimics.		
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Gellan	Gum		
Source	
Gellan	gum	is	an	exopolysaccharide	produced	by	bacteria	from	
the	 Sphingomonas	 group	 as	 a	 major	 constituent	 of	 their	
extracellular	 polymeric	 substance	 (EPS).	 Commercially,	 gellan	
gum	 is	 usually	 produced	 by	 batch	 fermentation	 using	 the	
Sphingomonas	paucimobilis	strain,	due	to	the	higher	yields	and	
purity	of	GG	achieved	with	this	species27.	GG	is	extracted	from	
this	broth	by	a	multi-step	process.	Firstly,	 the	broth	 is	heated	
at	elevated	pH,	 followed	by	centrifugation	or	hot	 filtration	 to	
separate	 cell	 bodies	 from	 the	 EPS.	 Multiple	 rounds	 of	
precipitation,	resuspension	and	dialysis	are	then	used	to	purify	
GG,	 which	 is	 then	 dried	 or	 lyophilized	 and	 distributed	 as	 a	
powdery,	 off-white	 solid.	 The	 quantity,	 purity,	 and	 physical	
characteristics	 of	 extracted	 gellan	 depend	 on	 many	 factors	
including	cell	population,	nutrient	feedstock,	temperature,	pH,	
and	 extraction	 procedure28.	 A	 detailed	 review	 of	 gellan	 gum	
biosynthesis	can	be	found	in	Fialho	et	al.29.	
	
Structure	
The	 gellan	 gum	 polysaccharide	 is	 a	 repeating	 tetramer	
comprised	of	L-rhamnose,	D-glucuronic	acid	and	two	D-glucose	
subunits.	 In	 its	 native	 state,	 these	 tetramers	 also	 contain	
glycerate	and	acetate	functionalities,	however	the	hot	alkaline	
conditions	employed	in	GG	extraction	leads	to	their	reduction	
to	hydroxyl	residues	(Figure	2).	Works	exploring	the	functional	
impacts	of	deacylation	may	be	 found	 in30-33,	however	TE	with	
gellan	gum	is	most	commonly	performed	using	the	deacylated	
form	 due	 to	 the	 relative	 ease	 of	 isolation	 and	 processing.	 In	
hot	 aqueous	 dispersion,	 both	 high	 and	 low-acyl	 gellan	 gum	
chains	are	randomly	distributed	 in	solution,	but	self-assemble	
into	 helix	 pairs	 upon	 cooling	 through	 a	 sol-gel	 transition	
temperature	 (~50	 ˚C).	 This	 process	 is	 a	 critical	 step	 in	 the	
gelation	of	GG,	which	will	be	discussed	later.		
	
	
Figure	 2:	 Gellan	 Gum:	 The	 chemical	 structures	 of	 gellan	 gum	 as	 produced	 by	
Sphingomonas	 sp.,	 and	 its	deacylated	 form	 that	 is	more	 commonly	employed	 for	GG	
tissue	engineering.	
Purification	and	Sterilisation	
All	 materials	 intended	 for	 tissue	 engineering	 applications	
require	 a	 high	 degree	 of	 purification	 and	 quality	 control	 to	
ensure	the	product	is	both	safe	and	reliable.	This	is	particularly	
true	 for	 scaffolds	 intended	 for	 implantation,	where	 infection,	
inflammation	 and	 immunogenicity	 are	 of	 concern.	 In	 most	
cases,	 GG	 products	 need	 to	 be	 sterilised	 prior	 to	 use	 in	 cell	
culture	and	TE.	Various	techniques	are	in	use	for	this	purpose	
including	 autoclaving34-36,	 ethylene	 oxide	 treatment37,	 micro-
filtration38,	and	antibiotic	 supplements39.	Although	no	studies	
directly	compare	these	methods	with	respect	to	their	impacts	
on	GG,	equivalent	investigations	using	other	polysaccharides40-
43	 and	ECM	materials40,	 44,	 45	provide	a	good	 indication	of	 the	
likely	 effects	 on	 GG.	 In	 general,	 these	 studies	 report	 that	
common	 sterilisation	 procedures	 are	 generally	 effective	 at	
removing	 or	 deactivating	 contaminants	 without	 loss	 of	 the	
biological	 activity.	 However,	 heat-based	 techniques	 may	
decrease	the	molecular	weight	of	polymer	chains	and	thereby	
alter	the	rheology	of	polysaccharide	solutions	and	gels.	Whilst	
such	 effects	 in	 no	way	 preclude	 the	 use	 of	 heat-sterilisation,	
GG	scaffolds	and	handling	procedures	need	to	be	designed	in	a	
manner	that	accounts	for	the	likely	impacts	of	sterilisation.		
	
As	 well	 as	 live-cell	 contamination,	 bacteria-derived	 materials	
such	as	GG	are	susceptible	to	contamination	with	endotoxins,	
which	 have	 the	 potential	 to	 trigger	 immunogenic	 reactions,	
and	thereby	compromise	implanted	scaffolds.	For	this	reason,	
scaffolds	 intended	 for	 cell	 culture,	particularly	 in	 vivo	 testing,	
should	 be	 purified	 of	 endotoxins.	 Several	 methods	 exist	 for	
endotoxin	 removal,	 including	 phase	 separation,	
chromatographic	 and	 ultrafiltration	 techniques46,	 and	 the	
levels	of	remnant	endotoxins	can	be	quantitatively	determined	
using	 limulus	 amoebocyte	 lysate	 (LAL)	 tests.	 However,	 low-
endotoxin	 GG	 products	 such	 as	 Gelzan	 are	 commercially	
available47,	and	will	likely	be	an	appropriate	feedstock	material	
for	most	GG	tissue	engineering	purposes.	
	
As	well	 as	 biological	 contamination,	 GG	 is	 highly	 sensitive	 to	
the	 presence	 of	 salts,	 particularly	 divalent	 and	 multivalent	
cations48,	 49.	Whilst	not	biologically	detrimental,	 these	cations	
can	substantially	alter	the	physical	properties	of	GG	hydrogels	
as	well	as	the	processing	behaviours	of	GG	solutions.	Recently,	
Kirchmajer	et	al.	reported	that	the	removal	of	divalent	cations	
from	GG	greatly	 increased	the	ease	of	hydrating	the	polymer,	
improved	 solution	 clarity	 and	 lead	 to	 a	 more	 controlled	 and	
homogeneous	gelation50.	Ferris	et	al.	noted	the	purification	of	
commercial	 GG	 to	 its	 sodium	 salt	 form,	 NaGG,	 was	 a	
prerequisite	 for	 further	 functionalisation51.	 For	 optimum	
processability	 and	 material	 consistency,	 researchers	 should	
consider	 including	 salt	 purification	 as	 a	 routine	 step	 in	 their	
application	of	GG.	Both	Kirchmajer,	and	earlier	works	by	Doner	
et	 al.52,	 53	 provide	 procedures	 for	 the	 purification	 of	 GG	 to	
monovalent	salt	forms.	
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Gelation	
One	of	the	defining	properties	of	the	GG	polysaccharide	is	the	
ability	 to	 form	 pseudo-solid	 structures	 known	 as	 hydrogels.	
These	 structures	 are	 formed	 from	 the	 interlocking	 of	 GG	
chains	into	a	single,	coherent	network	that	entraps	a	very	high	
(~99	 %)	 volume	 fraction	 of	 water.	 The	 formation	 of	 this	
network	 is	 driven	 by	 the	 spontaneous	 aggregation	 of	 GG	
chains	 from	a	 ‘random	coil’	 state,	 to	paired	helical	 structures	
as	 they	 cool	 through	 the	 sol-gel	 transition	 temperature49,	 54.	
Multiple	GG	helices	then	aggregate	into	junction	zones	that	act	
as	 cross-linking	 sites	 for	 the	 network.	 This	 structure	 was	
initially	 resolved	 by	 Gunning	 and	 Morris	 using	 light	
scattering55,	 and	 later	 observed	 directly	 using	 atomic	 force	
microscopy56-58.	 Importantly,	 the	 junction	 zones	 of	 GG	
networks	 are	 strongly	 stabilised	 by	 multivalent	 cations,	
commonly	 Ca2+	 or	 Mg2+,	 and	 the	 presence	 of	 these	 species	
renders	 the	 gelation	 of	 GG	 practically	 irreversible48.	 Many	
authors	 leverage	 this	phenomenon	 to	generate	GG	hydrogels	
that	 are	 ‘physically	 cross-linked’	 through	 the	 presence	 of	
cation-stabilised	 junction	zones	of	helical	GG	chains.	Tailoring	
the	concentrations	of	GG	and	cations	present	in	solution	prior	
to	cooling	allows	for	a	modulation	of	many	physical	properties	
of	 the	 resulting	 hydrogels59.	 A	 thorough	 review	 of	 the	
structure,	 physical	 properties	 and	 gelation	 mechanism	 of	
gellan	gum	can	be	found	in	Morris	et	al.54.		
	
Degradation	
For	 tissue	 engineering	 applications,	 the	 pathways,	 timeframe	
and	by-products	of	biodegradation	are	important	in	the	design	
and	application	of	cell	scaffolding	biomaterials23.	A	number	of	
authors	 have	 attempted	 to	 investigate	 the	 degradation	
behaviours	 of	 GG	 both	 in	 vitro	 and	 in	 vivo.	 Long-term	
degradation	behaviour	 in	PBS	 for	pure	GG60,	and	blended	GG	
networks61	 has	 been	 reported.	 In	 both	 cases,	 gels	 were	
observed	to	lose	10–15	%	of	their	starting	mass	over	periods	of	
up	 to	 168	 days.	 Lee	 et	 al.	 studied	 weight	 loss	 in	 pure	 and	
blended	GG	scaffolds	during	immersion	in	cell	culture	media	as	
part	 of	 a	 study	 optimising	 gels	 for	 fibrocartilage	 tissue	
engineering,	 reporting	 10–20	 %	 weight	 loss	 over	 20	 days62.	
Degradation	 is	 substantially	 accelerated	 under	 alkaline	
conditions,	with	Coutinho	et	al.	reporting	methacrylated	GG	to	
loose	between	20–100%	of	starting	mass	over	24	h	in	0.1	mM	
NaOH,	 with	 rates	 depending	 on	 the	 degree	 of	 photo-cross-
linking63.	 Degradation	 rates	 may	 also	 be	 influenced	 by	 the	
presence	 of	 enzymes,	with	 Singh	 et	 al.	 reporting	 accelerated	
viscosity	 loss	 and	 drug	 release	 from	 GG	 beads	 in	 simulated	
colonic	 media	 containing	 the	 enzyme	 galactomannanase64.	
Finally,	 Jahromi	et	al.	studied	the	degradation	of	GG,	alginate	
and	 pectin	 after	 seeding	 each	 material	 with	 bone	 marrow	
stromal	 cells,	 finding	GG	degradation	 to	be	 the	 least	 rapid	of	
the	three	materials	65.	
	
A	 number	 of	 studies	 have	 assessed	 the	 performance	 of	 GG	
scaffolds	 in	 vivo.	 For	 example,	 Oliveira	 et	 al.	 implanted	 GG-
based	 scaffolds	 in	 rabbit	 cartilage	 defects	 for	 8-weeks66,	
reporting	 that	 adipose	 stem	 cells	 and	 chondrocytes	
encapsulated	 in	 GG	 scaffolds	 both	 remodelled	 that	 scaffold	
and	integrated	it	with	surrounding	cartilage	tissue.	 In	another	
study	Silva-Correia	et	al.	 implanted	GG	and	methacrylated	GG	
subcutaneously	for	10-18	days.	The	authors	reported	minimal	
inflammatory	 response	 and	 endothelial	 cell	 infiltration,	
however	 methacrylated	 GG	 was	 also	 observed	 to	 impede	
vascularisation67,	68.		
	
Overall,	 these	 studies	 present	 positive	 indications	 that	 GG	
biodegrades	 over	 a	 period	 of	 weeks	 to	months,	 and	may	 be	
suitable	for	a	wide	range	of	tissue	types.	However	the	studies	
have	 so	 far	 been	 directed	 towards	 a	 limited	 range	 of	 tissue	
types	and	conditions,	providing	only	a	partial	understanding	of	
GG’s	 degradation	 pathways	 and	 kinetics.	 Studies	 that	 more	
completely	 explore	 these	 pathways	 would	 be	 of	 benefit	 to	
future	GG	tissue	engineering.		
Blends	of	Gellan	Gum		
Engineered	 tissues	 are	 complex	 and	 highly	 sensitive	 systems	
that	 require	 application-specific	 tailoring	 of	 the	 physical,	
biological,	 morphological	 and	 processing	 properties	 of	
component	 materials13.	 GG	 was	 recently	 highlighted	 for	 its	
significant	 capacity	 for	 tissue	 engineering	 applications,	
particularly	after	blending	or	chemical	modification69.	Here,	we	
will	discuss	the	numerous	modifications	and	blends	that	have	
been	 employed	 to	 tailor	 the	 biological,	mechanical,	 chemical	
and	electrical	functionality	of	GG.	
	
Blending	for	Biofunctionality	
Many	 mammalian	 cells	 are	 ‘anchorage	 dependant’,	 meaning	
that	 their	 survival	 and	 phenotypic	 behaviour	 is	 strongly	
dependant	 on	 successful	 attachment	 to	 a	 matrix	 material.		
Although	the	GG	polysaccharide	is	cytocompatible,	it	does	not	
participate	 in	 the	 specific	 cell	 binding	 interactions69.	 As	 a	
result,	anchorage	dependant	cells	grown	 in	pure	GG	matrices	
may	 exhibit	 low	 levels	 of	 cell	 attachment	 or	 anomalous	
differentiation	 behaviours.	 One	 approach	 for	 resolving	 this	
issue	is	to	blend	GG	with	bioinformative	materials	that	induce	
regular	cell	behaviour.	For	example,	Cencetti	et	al.70,	Bellini	et	
al.34,	 Kang	et	 al.71,	 and	Cerquiera	et	 al.	 72	 have	each	blended	
GG	with	hyaluronic	acid	 (HA),	a	polysaccharide	present	 in	the	
mammalian	 ECM,	 to	 form	 engineered	 tissues	 for	 bone,	
intevertebral	 discs	 and	 vascularisation,	 respectively.	 The	ECM	
protein	 fibronectin	 has	 also	 been	 employed	 to	 improve	 cell	
binding	and	differentiation	in	GG	scaffolds	for	endothelial	cell	
entrapment73.	 Gelatin,	 a	 derivative	 of	 the	 ECM	 protein	
collagen,	 has	 also	 been	 incorporated	 into	 GG	matrices	 using	
enzymatic	binding74	and	genipin	cross-linking75,	improved	both	
the	 cell-GG	 interactions	 and	 mechanical	 strength	 of	 the	
resulting	 hybrid	 gels.	 Such	 approaches	 that	 simultaneously	
improve	 cell-interaction	 and	mechanical	 integrity	 are	 notable	
because	 they	 address	 one	 of	 the	 other	 factors	 limiting	 the	
application	 of	water-swollen	hydrogels	 in	 TE,	 being	 their	 lack	
of	inherent	strength76.		
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Blending	for	Strength	
Engineering	 load-bearing	 tissues	 requires	 scaffolds	 that	
possess	a	high	level	of	mechanical	integrity,	however	different	
strategies	 are	 required	 if	 these	 load	bearing	 tissues	 are	 ‘soft’	
like	cartilage,	or	 ‘hard’	 like	bone.	For	bone	tissue,	researchers	
have	 used	 combined	 blending	 and	 bioconditioning	 processes	
to	 mineralise	 GG	 scaffolds.	 Douglas	 et	 al.	 mineralised	 GG	
scaffolds	 using	 the	 alkaline	 phosphatase	 enzyme	 to	 improve	
strength	and	stiffness	of	the	material,	as	well	as	promote	cell	
attachment	 and	differentiation35,	 77.	 Douglas	 and	 others	 have	
also	 explored	 incorporating	 bioglass	 into	 GG	 hydrogels	 to	
improve	 mineralisation,	 bone	 regeneration	 and	 antibacterial	
properties78,	79.	Jamshidi	et	al.	achieved	similar	effects	through	
the	 direct	 blending	 of	 GG	 with	 nanocrystalline	
hydroxyapatite80,	 whilst	 Veira	 enhanced	 biomineralisation	
using	gold	nanorods	that	had	been	surface-functionalised	with	
GG81.	 Shin	 et	 al.	 also	 found	 elevated	 osteogenesis	 when	 GG	
microgels	 were	 employed	 for	 the	 reinforcement	 of	 a	 gelatin	
hydrogel	intended	for	bone	tissue	engineering82.	Finally,	hard-
soft	 tissue	 interfaces	 have	 also	 been	 explored	 with	 GG	
hydrogels	 set	 alongside	 brushite	 cement,	 forming	 structures	
akin	to	the	bone-cartilage	interface83.	
	
The	 bioengineering	 challenge	 of	 forming	 cartilage	 and	 other	
soft,	yet	 load	bearing,	tissue	scaffolds	 is	another	highly	active	
sub-discipline	 of	 TE.	 Towards	 this	 goal,	 numerous	 ‘tough	
hydrogels’	 have	 been	 formed	 through	 the	 combination	 of	
network	 elements	 with	 differing	 failure	 mechanisms	 that	
collectively	 distribute	 applied	 stresses.	 Reviews	 of	 these	
approaches	 and	 future	 perspectives	 can	 be	 found	 in	 Zhao76	
and	Costa	et	al.84.	Gellan	gum	has	commonly	been	employed	
in	 ‘ionic	 covalent	 entanglement’	 (ICE)	 systems.	 Various	
secondary	 networks	 have	 been	 reported	 including	
poly(acrylamide)85,	epoxy-amines86,	gelatin74,	75	and	hyaluronic	
acid87.	 It	 is	 considered	 likely	 that	 incorporating	 secondary	
networks	 with	 biofunctional	 or	 cell	 attachment	 behaviours,	
notably	 gelatin	 or	 hyaluronan,	 present	 the	 most	 promising	
routes	towards	engineering	cartilage	replacements.		
	
As	 well	 as	 ICE	 networking,	 other	 reinforcement	 approaches	
have	also	been	reported.	Park	et	al.	blended	GG	with	the	PLGA	
microspheres	to	create	a	reinforced	scaffold	for	intervertebral	
disc	scaffolds88.	Microgels	formed	from	blends	of	low	and	high-
acyl	 GG	 have	 also	 been	 tested	 as	 a	means	 of	 reinforcing	 GG	
hydrogels	for	intervertebral	disc	TE	89.	Thorvaldsson	reinforced	
GG	 with	 electrospun	 nanofibers	 of	 poly-ε-caprolactone	 for	
nucleus	 pulposus	 engineering90.	 Silva	 et	 al.	 reported	 a	 GG,	
starch	 and	 poly-ε-caprolactone	 system	 for	 spinal	 cord	 injury	
repair91.	Finally,	wet	spun	chitosan	fibers	have	been	employed	
as	a	reinforcing	material	for	high-acyl	gellan	gum	hydrogels92.	
	
Blending	for	Conductivity	
Blending	has	also	been	employed	as	a	route	for	the	formation	
of	 conductive	 hydrogels,	 which	 may	 be	 of	 use	 in	 forming,	
stimulating	 and	 recording	 from	 electrically	 excitable	 tissues	
such	as	muscle	and	nerve93-96.	Carbon	nanotubes97,	 98,	 carbon	
nanofibers99	 organic	 conducting	 polymers99,	 100,	 and	
graphene71,	 have	 all	 been	 successfully	 dispersed	 into	 GG	
systems,	whilst	gellan	gum	has	also	been	used	as	a	dopant	for	
electropolymerised	 conductive	 polymer	 surfaces	 for	 neural	
electrodes101.	 To	 date,	 there	 are	 few	examples	 of	 conductive	
GG	systems	being	applied	 in	 vivo	 towards	clinical	application,	
however	the	systems	have	generally	appeared	most	promising	
when	 applied	 as	 electrode	 surfaces	 with	 low	 water	 content,	
rather	than	as	water-swollen	hydrogels.	
Chemical	Modification	of	Gellan	Gum	 
An	alternative	 pathway	 for	 altering	 the	 functionality	 of	GG	 is	
through	 covalent	 chemical	 modification.	 Broadly	 speaking,	
chemical	 modifications	 of	 GG	 have	 been	 targeted	 towards	
similar	 applications	 as	 for	 blending,	 notably	 improved	 cell	
binding	 and	 mechanical	 integrity.	 However,	 chemical	
modification	also	provides	a	route	for	adding	new	functionality	
to	 the	 main	 gellan	 gum	 chain,	 including	 photo-cross-linking,	
self-assembly	and	drug	delivery.		
	
Methacrylation	and	Cross-Linking	
One	of	the	most	frequently	performed	covalent	modifications	
of	 gellan	 gum	 is	 methacrylation.	 This	 moiety	 is	 popular	
because	 it	 enables	 photo-initiated	 cross-linking,	 providing	 an	
alternative	cross-linking	mechanism	that	can	also	be	employed	
to	 covalently	 link	 GG	 to	 other	 polymers	 and	 molecules.	
Methacylated	gellan	gum	(MA-GG)	is	generally	produced	using	
methacrylic	 anhydride82,	 87,	 102-104.	 An	 optimisation	 of	
methacrylation	 density	 and	 UV	 dose	 time	 can	 be	 found	 in	
Bartnikowski	 et	 al.105,	 and	 the	 mechanical	 and	 biological	
performance	of	MA-GG	has	been	reported	by	Silva-Correia	et	
al.67,	106.	Because	it	provides	GG	with	a	secondary	cross-linking	
action	 that	 is	 somewhat	 controllable,	 MA-GG	 is	 most	 often	
applied	 for	 the	 fabrication	 of	 load	 bearing	 tissues	 such	 as	
intervertebral	 discs37,	 63,	 102,	 104	 and	 cartilage105.	 As	 with	
unmodified	GGs,	MA-GGs	have	also	been	blended	with	other	
polymers	 including	 hyaluronic	 acid87	 and	 gelatin82,	 103,	 to	
improve	cell	attachment	and	differentiation.		
	
As	 well	 as	 methacrylation,	 a	 number	 of	 alternative	 covalent	
cross-linkers	have	been	applied	 to	GG.	For	example,	a	photo-
cross-linking	 effect	 similar	 to	 MA-GG	 has	 been	 achieved	 by	
binding	GG	with	cinnamate107,	 in	 this	case	 for	 the	purpose	of	
anti-adhesion	 coatings.	 Lee	 et	 al.	 reported	 a	 carboimmide	
(EDC)	coupled	GG	 that	 spontaneously	 cross-links	 to	 form	gels	
with	 enhanced	 mechanical	 strength	 for	 wound	 healing	
applications108.	Finally,	Hamcerencu	et	al.	reported	a	series	of	
esterified	 GGs	 with	 cross-linking	 and	 copolymerisation	
potential109.	
	
Peptides	and	Biofunctionality	
As	 with	 blending,	 numerous	 authors	 have	 sought	 to	 apply	
covalent	 modification	 techniques	 to	 tailor	 the	 biofunctional	
behaviours	of	GG.	For	example,	Silva	et	al.110	and	Ferris	et	al.51	
have	 both	 covalently	 coupled	 GG	 with	 short	 peptides	
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containing	 the	 arginyl-glycyl-aspartic	 acid	 (RGD)	 sequence,	 a	
motif	 derived	 from	 the	 cell	 attachment	 sites	 of	 ECM	
materials111.	 The	 covalent	 attachment	 of	 RGD	 to	 GG	 induces	
cells	to	actively	bind	with	the	polysaccharide	as	they	would	for	
natural	ECM,	improving	growth	and	differentiation	behaviours	
of	 neural	 stem/progenitor	 cells110,	mesenchymal	 stem	 cells39,	
muscle	 cell	 lines51	 and	 primary	 cortical	 neural	 tissues38.	 It	 is	
evident	 from	 these	 reports	 that	 the	 inclusion	 of	 cell-binding	
moieties	in	GG	hydrogels	has	significant	and	positive	impact	on	
encapsulated	 cells,	 however,	 it	 is	 less	 clear	 whether	 such	
covalent	 attachment	 of	 cell	 binding	 peptides	 is	 more	 or	 less	
effective	 than	 directly	 blending	 GG	 with	 ECM	 materials.	
Nevertheless	 most	 engineered	 GG	 tissues	 will	 likely	 benefit	
from	the	application	of	at	least	one	of	these	strategies.	
	
Other	Chemical	Modifications		
As	well	as	peptide	binding	and	cross-linking,	a	number	of	other	
functional	 groups	 have	 been	 attached	 to	 GG.	 D’Arrigo	 et	 al.	
covalently	 coupled	 GG	 with	 prednisolone,	 yielding	 a	 self-
assembling	nano-hydrogel	that	retained	the	anti-inflammatory	
properties	 of	 prednisolone112.	 Novac	 et	 al.	 reported	 the	
synthesis	 of	 aminated	 carboxymethyl-GG	 derivatives113,	
targeted	 towards	 central	 nervous	 system	 drug	 delivery.	 This	
work	was	 later	extended	to	create	an	antibacterial	GG	hybrid	
that	supported	the	controlled	release	of	ciprofloxacin	towards	
dermal	 repair	 applications114.	 Hamcerencu	 produced	 three	
esterified	 GG	 derivatives,	 with	 the	 new	 functional	 groups	
providing	 potential	 active	 sites	 for	 a	 wide	 variety	 of	 further	
modification	 and	 cross-linking	 processes109.	 Individually,	 the	
modification	 processes	 recounted	 here	 are	 designed	 to	
enhance	the	material’s	usefulness	towards	a	particular	target.	
In	 many	 cases,	 however,	 there	 is	 potential	 for	 cross-
fertilisation,	 where	 GG	 reportedly	 modified	 for	 soft	 tissues	
may	 be	 useful	 for	 bone	 regeneration	 and	 vice	 versa.	 The	
continued	 exploration	 of	 GG,	 and	 the	 broad	 spectrum	 of	
chemical	 derivatives,	 will	 likely	 identify	 many	 untested	
applications	for	this	highly	versatile	TE	platform.		
Physical	Modification	of	Gellan	Gum		
Finally,	 tailoring	 the	 properties	 of	 GG	 for	 TE	 application	 can	
also	be	achieved	 through	physical	modifications	of	GG	chains	
or	 hydrogel	 macrostructure.	 In	 general	 these	 processes	 are	
undertaken	 to	 optimise	 the	 mechanical,	 rheological	 and	
processing	properties	of	GG.			
	
Molecular	Weight	
The	 elasticity	 of	 tissue	 scaffolds	 plays	 an	 important	 role	 in	
influencing	 the	 behaviour	 of	 encapsulated	 cells115,	 116.	 In	 a	
laboratory	setting,	the	elasticity	of	GG	scaffolds	can	be	readily	
tailored	 by	 controlling	 the	 concentration	 of	 cations,	 and	
therefore	 cross-linking	 density.	 However,	 scaffolds	 applied	 in	
vivo	 will	 generally	 equilibrate	 to	 physiological	 ion	
concentrations,	 limiting	 the	scope	 for	controlling	cross-linking	
through	 ion	 availability.	 An	 alternative	 means	 of	 modulating	
the	elasticity	of	GG	hydrogels	 is	to	alter	the	molecular	weight	
(MW)	of	the	polysaccharide,	which	influences	many	aspects	of	
hydrogel	 strength	 and	 rheology.	 To	 this	 end,	 Gong	 et	 al.	
employed	 sodium	 periodate	 (NaIO4)	 as	 a	 chemical	 scissor	 of	
GG	 chains,	 tailoring	 chain	 lengths	 for	 application	 in	 cartilage	
repair117.	Goh	et	al.118	and	Moxon	et	al.119	have	both	achieved	
a	 similar	effect	using	ultrasonication,	allowing	 for	modulation	
of	 gel	 properties	 whilst	 retaining	 physiological	 cross-linking	
rates119.		
	
Figure	 3:	 	 Chemical	Modifications	 of	 Gellan	 Gum:	A	 selection	 covalently	modified	 GGs	 that	 have	 been	 reported	 to	 tailor	 GG’s	mechanical	 strength,	 cross-linking	 behaviour,	
biofunctionality	and	reactivity.	The	majority	of	GG	functionalisation	reactions	target	the	carboxylate	and	hydroxyl	residues.	Presented	structures	are	collated	from	original	reports	
in	Lee	et	al.	107,	Pacelli	et	al.	104,	Silva-Correia	et	al.	37,	Hamcerencu	et	al.	109,	Silva	et	al.	110	and	Ferris	et	al.	51	
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As	 noted	 previously,	 heat	 treatments	 induce	 a	 similar	 chain-
shortening	 effect.	 To	 date	 no	 studies	 have	 employed	 heat	
treatment	 as	 a	means	of	 intentionally	 tailoring	 chain	 lengths,	
however	 autoclaving	 could	 conceivably	 be	 employed	 to	
simultaneously	 sterilise	 and	 optimise	 rheology	 in	 GG	
dispersions.		
	
Altered	Gelation	
Finally,	 several	 authors	 have	 drastically	 altered	 the	 form	 and	
functionality	of	GG	hydrogels	by	disrupting	the	network	either	
during,	or	 following	gelation.	 For	example,	 cast	GG	hydrogels	
that	are	subsequently	 freeze-dried	and	rehydrated	have	been	
reported	to	have	increased	strain	recovery	and	support	better	
differentiation	 in	 encapsulated	 human	 adipose	 stem	 cells73.	
Similar	 lyophilised	 ‘GG	 sponge’	 systems	 have	 also	 been	
suggested	 for	 use	 as	 a	 dental	 filling	 material120.	 Microgel	
suspensions	of	GG	have	also	been	variously	reported,	including	
the	 creation	of	a	bio-ink	 from	GG	 that	was	gelled	under	high	
shear	to	form	a	loosely	bound	microgel	suspension121.	The	bio-
ink	 was	 employed	 to	 prevent	 cell	 settling	 during	 ink-jet	
printing,	allowing	high	accuracy	cell	patterning	down	to	single-
cell	 resolution.	 Shin	 et	 al.	 created	 similar	microgels	 from	GG	
using	a	water-oil	emulsion	technique82,	which	were	utilised	for	
reinforcement.	Pereira	et	al.	have	also	described	the	formation	
of	microgels	by	cross-linking	blends	of	low	and	high-acyl	GG	in	
a	 PBS	 bath	 under	 agitation89.	 Montanari	 et	 al.	 employed	 an	
autoclave	 to	 form	even	 smaller	 ‘nanogels’	 from	a	 cholestorol	
derivative	 of	 GG36.	 The	 technique	 was	 highlighted	 for	 its	
simultaneous	 formation	 and	 sterilisation	 of	 the	 nanogels,	
which	were	intended	for	drug	release.	
	
Overall	it	can	be	seen	that	a	diverse	array	of	modifications	can	
be	 successfully	 applied	 to	 GG	 though	 physical,	 chemical	 and	
blending	 processes.	 By	 virtue	 of	 these	modifications,	 GG	 has	
been	rendered	suitable	for	the	formation	of	tissues	as	diverse	
as	 bone,	 muscle,	 cartilage,	 dermis	 and	 the	 neural	 cortex.	 A	
summary	 of	 the	 modifications	 made	 to	 GG	 for	 tissue	
engineering	 applications	 is	 presented	 in	 Table	 1.	 These	
examples	 highlight	 the	 incredible	 versatility	 of	 GG,	 which	 is	
probably	best	considered	as	a	processable	and	biocompatible	
backbone	material,	 onto	which	 a	wide	 variety	 of	 application-
specific	 functionality	 can	 be	 built.	 The	 next	 section	will	 focus	
on	 how	 these	 materials	 may	 be	 successfully	 patterned	 into	
complex	tissue	structures	using	biofabrication	technologies.		
	
	
ARTICLE	 Journal	Name	
8 	|	J.	Name.,	2012,	00,	1-3	 This	journal	is	©	The	Royal	Society	of	Chemistry	20xx	
Please	do	not	adjust	margins	
Please	do	not	adjust	margins	
	
Table	1:	 Summary	of	 the	blending	and	modification	processes	performed	on	gellan	gum	to	 improve	 its	usefulness	 in	 tissue	engineering	applications.	Acronyms	are	defined	as	
follows:	CHPTMAC	(N-(3-chloro-2-hydroxy-propyl)-trimethyl	ammonium	chloride),	CNS	(Central	Nervous	System),	EDAC	(1-Ethyl-3-(3-dimethylaminopropyl)	carbodiimide),	EDC	(1-
Ethyl-3-(3-dimethylaminopropyl)carbodiimide)),	LAGG	(Low-acyl	gellan	gum),	HAGG	(High-acyl	gellan	gum),	hASC	(human	Adipose	Stem	Cells),	NHS	(N-hydroxysuccinimide),	NMP	
(N-methyl-2-pyrrolidone),	 PAA	 (poly(acrylic	 acid)),	 PAH	 (poly(allyamine	hydrochloride)),	 PBS	 (phosphate	buffered	 saline),	 PCL	 (poly-ε-caprolactone),	 PLA	 (poly(lactic	 acid)),	 PVA	
(poly(vinyl	alcohol),		
	
	
Category Material / Modification 
Key Method / 
Reactant Impact
Target Tissue / 
Application Reference
Blending
Hyaluronic acid Mixing at RT  Cell binding Bone Bellini 2015
Hyaluronic acid Mixing at 90 ˚C Cell binding Vasculature Cerqueira 2014
Gelatin/genipin  Mixing at 80 ˚C
Reinforcement + 
Cell binding Unspecified Kirchmajer 2014
Poly(acrylamide) Mixing at 70 ˚C Reinforcement Unspecified Bakarich 2012 
PLGA Microspheres Mixing at 45 ˚C Reinforcement Vertebra Park 2015
Gelatin/enzymes 
Microbial 
transglutaminase
Reinforcement + 
Cell binding Unspecified Wen 2013
Gold nanorods 
PAA/PAH 
Pretreatment
Strength + 
Microstructure  Bone Veira 2015
Bioglass
SiO2, CaO, 
Na2O, P2O5
Strength + 
Biomineralisation Bone
Douglas 2014
Gantar 2014
Carbon nanotubes Ultrasonication Conductivity Unspecified Ferris 2009 
Graphene oxide Ultrasonication
Conductivity
Reinforcement Unspecified Kang 2015
PEDOT +  
Carbon nanofibers Ultrasonication Conductivity Unspecified Warren 2014
HAGG/LAGG blends 
Methacrylation + 
Hyaluronic acid
Mixing at 70 ˚C
Photocross-linking, 
Reinforcement, 
Cell binding
Intervertebral discs Khang 2015
Methacrylation + 
Gelatin-methacrylate
Methacrylic 
anhydride
Photocross-linking 
Reinforcement
Load bearing 
tissues Shin 2012
Methacrylation +  
GG Microspheres +
Gelatin
Methacrylic 
anhydride
Water-oil emulsion
Reinforcement
Load bearing 
tissues Shin 2014
Chemical 
Modifications
Methacrylation  
PEG-DMA
Methacrylic 
anhydride
Photocross-linking 
Reinforcement Unspecified Pacelli 2015
Methacrylation
Glycidyl 
methacrylate
Photocross-linking 
Reinforcement Intervertebral discs
Coutinho 2010 
Silva-Correia 2011
Cinnamate Cinnamyl bromide
Photocross-linking 
Anti-adhesion Wound healing Lee 2012
Esterification
Acryloyl chloride
Acrylic acid 
Maleic anhydride
Reactivity  
Cross-linking Drug delivery Hamcerencu 2008 
Aminated 
carboxymethylation EDAC Unspecified Drug delivery Novac 2013
Quaternary amine  CHPTMAC
Drug Release 
Antibacterial  Dermal repair Novac 2014
Prednisolone NMP
Self-assembly 
Anti-inflammatory Drug delivery D’Arrogo 2012
G4RGDSY Peptide
EDC, NHS 
coupling 
Improved cell 
binding Muscle Ferris 2015 
GRGDS Peptide Diels Alder
Improved cell 
binding Spinal chord/CNS 
Silva 2012  
Silva 2013
EDC Cross-linking  EDC Reinforcement Wound healing Lee 2010
Reduced Chain Length  NaIO4 Scissoring
Hydrogel 
Softening Cartilage Gong 2008
Physical 
Modifications
Increased pore size Freeze Drying
Improved cell 
scaffolding
Human adipose 
stem cells da Silva 2014 
Microgel Vortex Mixing
Controlled cell 
settling Cell Printing Ferris 2013 
Microgel
HAGG/LAGG  
PBS Coagulation Reinforcement Intervertebral discs Pereira 2011 
Reduced Chain Length  Ultrasonication
Hydrogel 
Softening Unspecified
Goh 2015
Moxon 2016
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Biofabrication	with	Gellan	Gum		
Hydrogel	 forming	 biopolymers	 can	 be	 processed	 into	 3D	
structures	 using	 a	 variety	 of	 emerging	 biofabrication	
technologies17,	 122,	 123.	 Reviews	 on	 the	 principles	 and	
applications	 of	 these	 technologies	 can	 be	 found	 in	 Mota	 et	
al.16,	 Arslan-Yildiz	 et	 al.124	 or	 Murphy	 and	 Atala10.	 When	
compared	 with	 other	 hydrogel	 forming	 biopolymers,	 GG	 has	
received	very	 little	attention	 in	 the	biofabrication	 literature14,	
125,	 and	 most	 of	 the	 reported	 GG	 cell	 scaffolds	 have	 been	
produced	by	casting	approaches	(Fig.	4A).	Despite	it’s	relatively	
niche	status	in	biofabrication	science,	GG	is	in	fact	amenable	to	
a	wide	array	of	handling	processes,	demonstrated	by	Oliveira	
et	al.	through	the	formation	of	cast	discs,	films,	fibers,	spheres	
and	 lyophilized	 scaffolds	 of	 GG126.	 A	 clear	 pathway	 forwards	
for	 GG	 tissue	 engineering	 is	 through	 applying	 the	 material	
across	 the	 many	 emerging	 biofabrication	 technologies.	 The	
following	 section	 covers	 the	 limited	 present	 literature	 on	GG	
biofabrication,	and	highlights	possible	directions	for	advancing	
the	field	in	the	short	term.				
	
Bioprinting	
Beyond	casting	approaches,	the	formation	of	GG	scaffolds	has	
been	most	reliably	been	achieved	with	bioprinting	techniques.	
In	 this	 broad	 space,	 GG	 has	 been	 applied	 as	 a	 cell	 carrier,	
rheology	modifier	or	structural	material,	and	processed	across	
both	 ink-jet	 and	 extrusion	 printers.	 Across	 all	 of	 these	
approaches,	 a	 unifying	 theme	 is	 the	need	 to	 control	 the	 rate	
and	timing	of	cross-linking.	For	example,	Ferris	et	al.	produced	
a	novel	GG	bio-ink	by	pre-gelling	GG	under	high	shear	to	form	
a	 suspension	 of	 GG	 microgels121.	 When	 supplemented	 with	
biocompatible	 surfactants,	 these	 GG	 microgel	 suspensions	
were	 shown	 to	 be	 highly	 amenable	 to	 ink-jetting,	 and	
reportedly	 stabilised	 live	 cell	 cultures	 to	 enabling	 single-cell	
patterning	 (Fig.	 4B).	 This	 bio-ink	 has	 been	 applied	 for	 the	
patterning	 of	 single	 cell	 arrays	 for	 lipidomics	 127	 and	 for	 the	
placement	of	cells	within	wet-spun	alginate	fibers	128.	Applying	
these	GG	microgels	 alongside	 the	delivery	 of	 bulk	 scaffolding	
materials	may	present	a	means	of	forming	complex	and	high-
resolution	 tissue	 structures.	 Another	 bioprinting	 technique	
applied	 in	 the	patterning	of	GG	 is	 reactive	extrusion	printing,	
whereby	GG	is	delivered	simultaneously	with	Ca2+	ions.	Lozano	
et	 al.	 applied	 this	 technique	 in	 the	 fabrication	 of	 a	 multi-
layered	cortical	tissue	mimic	from	RGD-peptide	modified	GG38.	
Although	 extrusion	 based	 techniques	 are	 generally	 of	 lower	
resolution	 than	 ink-jetting,	 this	 reactive	 printing	 approach	
could	 conceivably	 be	 applied	 at	 high	 resolutions	 using	
microfluidic	approaches,	which	have	been	successfully	applied	
in	 for	 the	patterning	of	other	polysaccharide	materials	 129-133.	
Nevertheless,	reactive	extrusion	printing	represents	a	fast	and	
efficient	means	of	forming	large,	cell	laden	and	self-supporting	
GG	hydrogel	scaffolds.	
	
	
	
	
	
Figure	4:		Biofabrication	options	for	gellan	gum:	Schematic	representations	
of	 the	 formation	 of	 hydrogel	 scaffolds	 from	 gellan	 gum	 including	 casting,	
reactive	printing,	ink-jet	printing	and	wet	spinning.	To	date,	casting	has	been	
the	 primary	 means	 of	 forming	 GG	 scaffolds,	 however	 emerging	
biofabrication	 techniques	 are	 potentially	 applicable	 for	 a	 wide	 range	 of	
tissue	engineering	applications.	
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Gellan	gum	has	also	been	extrusion	printed	as	a	component	of	
blends	 with	 gelatin.	 Visser	 et	 al.	 incorporated	 GG/gelatin-
methacrylate	 hydrogels	 as	 part	 of	 a	 multi-material	 printing	
approach	 for	 the	 formation	 of	 complex	 tissue-shaped	
structures134.	 Levarto	 et	 al.	 also	 printed	 blends	 of	 gelatin	
methacrylamide	 and	 GG,	 in	 this	 case	 seeding	 cells	 into	 the	
scaffold	with	the	aid	of	poly(lactic	acid)	(PLA)	microcarriers135.	
In	 both	 cases,	 the	 researchers	 applied	 photo-crosslinking	 of	
the	methacrylated	gelatin	as	a	key	step	in	scaffold	fabrication.	
Such	UV	cross-linking	approaches	were	recently	highlighted	as	
a	 promising	 means	 of	 accurately	 controlling	 bioprinted	
scaffolds123.	 Although	 methacrylated	 gelatin	 has	 been	 the	
principal	material	 applied	 for	 this	 purpose	 to	 date136,	 137,	 the	
methacrylated	 gellan	 gums	 that	 have	 so	 far	 been	 photo-
polymerised	whilst	 confined	 in	 a	 casting	mould37,	 63,	 104	 could	
be	readily	applied	in	UV-bioprinting.	Extending	MA-GG	into	the	
field	 of	 UV-bioprinting	 presents	 a	 new	 mode	 of	 GG	
biofabrication	with	significant	future	potential.		
	
Overall,	 bioprinting	 presents	 a	 promising	 route	 towards	 GG	
tissue	 fabrication,	 and	 GG	 has	 already	 been	 utilised	 in	 both	
ink-jet	 and	 extrusion	 printing	 techniques.	 There	 remains	
significant	 opportunity	 for	 further	 developments	 in	 GG	
bioprinting,	 and	 the	 formation	 of	 complex	 tissues	 and	whole	
organ	 structures	 will	 likely	 require	 a	 combination	 of	 high-
resolution	and	high-throughput	techniques.		
	
Wet-Spinning	
Wet	 spinning	 is	 a	 technique	 in	which	 a	 feedstock	material	 is	
continuously	 fed	 into	 a	 coagulation	 bath,	 forming	 fiber	
structures	(Fig.	4D).	Pure	GG	fibers	may	be	formed	by	directly	
spinning	 GG	 solutions	 into	 baths	 containing	 divalent	 cations,	
akin	 to	 the	 fabrication	 of	 a	 wide	 range	 of	 alginate	 fibers138.	
Oliveria	 et	 al.	 demonstrated	 the	 formation	 of	 GG	 fibers	
through	 spinning	alkaline	GG	solutions	 into	a	bath	 containing	
ascorbic	acid	(vitamin	C)126.	Several	authors	have	also	reported	
the	 formation	 of	 poly-ion	 complex	 fibers,	 whereby	 the	
polyanionic	GG	is	spun	alongside	poly-cationic	materials139.	For	
example,	Granero	et	al.	reports	that	GG	fibers	spun	into	a	bath	
containing	chitosan	(and	vice	versa)	generating	complex	fibers	
with	 enhanced	mechanical	 properties140.	Meier	et	 al.	 created	
similar	 poly-ion	 complex	 fibers	 between	 GG	 and	 amyloid	
protein	 nanofibers,	 reporting	 the	 bio-fibers	 to	 have	 high	
strength,	 and	 potential	 for	 use	 in	 drug	 release	 and	 cell	
scaffolding141.	 Finally,	 Schirmer	 et	 al.	 recently	 applied	 GG	
microgels	to	deliver	cells	 in	defined	channels	within	wet-spun	
alginate	 fibers	 128.	 Although	 this	 study,	 and	 others	 138,	 apply	
alginate	as	the	primary	hydrogel	material,	the	similarity	in	the	
rheological	 and	 cross-linking	 behaviours	 of	 alginate	 and	 GG	
suggests	 that	 these	wet-spinning	 techniques	could	be	applied	
for	 the	 formation	 of	 GG	 fibers	 as	 well.	 Such	 wet-spun	 fibers	
may	be	highly	applicable	for	the	formation	of	tissue	structures	
that	require	directional	growth,	such	as	muscle	and	nerve.		
	
	
	
Other	techniques	
Alongside	the	work	in	bioprinting	and	wet-spinning,	a	number	
of	 niche	 approaches	 to	 GG	 biofabrication	 have	 also	 been	
reported.	 For	 example,	 Vashisth	 et	 al.	 recently	 reported	 the	
electrospinning	 of	 blended	 GG-poly(vinyl	 alcohol)	 (PVA)	 into	
fibrous	mats	which	may	 have	 potential	 as	 biodegradable	 cell	
scaffolds142.	 A	 combined	 electrospinning	 and	 air-brush	 GG	
delivery	technique	has	been	reported	for	the	formation	of	GG-
polycaprolactone	hybrids	 targeted	 towards	nucleous	pulposus	
regeneration90.	 ‘Spongy’	 GG-based	 cell	 scaffolds	 have	 been	
fabricated	 through	 multi-step	 casting	 and	 freeze	 drying	
processes72,	73,	which	de	Silva	et	al.	reported	to	improve	hASC	
differentiation,	particularly	when	fibronectin	was	swollen	 into	
the	 GG	 matrix	 during	 rehydration73.	 Similar	 freeze-dried	 GG	
scaffolds	have	been	covalently	cross-linked	with	EDC	to	render	
them	suitable	for	dental	filling	applications	120.	
	
A	 summary	 of	 the	 biofabrication	 processes	 applied	 to	 GG	 is	
presented	in	Table	2.	Although	the	array	of	processing	options	
for	GG	has	grown	markedly	over	the	last	five	years,	many	areas	
are	 yet	 to	 be	 explored.	 Notably,	 many	 of	 the	 biofabrication	
techniques	already	reported	for	materials	other	than	GG	may	
be	 readily	 applicable	 for	 GG.	 More	 specifically,	 the	 rheology	
and	gelation	mechanisms	of	GG	are	closely	 related	 to	 that	of	
alginate,	 a	 seaweed-derived	 polysaccharide	 that	 is	 already	
extensively	 employed	 in	 biofabrication	 and	 TE	 research.	 For	
this	 reason,	 many	 techniques	 in	 use	 for	 alginate	 processing	
could	 be	 directly	 applied	 to	 GG	 with	 minimal	 alteration.	
Applying	 conditions	used	 in	 alginate	 research,	 and	optimising	
from	there,	represents	a	highly	efficient	means	of	establishing	
reliable	processing	pathways	for	GG	and	its	derivatives.	
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Table	 2:	 Summary	 of	 the	 biofabrication	 processes	 performed	 in	 the	 patterning	 of	 gellan	 gum.	 Acronyms	 are	 defined	 as	 follows:	 EDC	 (1-Ethyl-3-(3-
dimethylaminopropyl)carbodiimide)),	GG	(Gellan	Gum),	hASC	(human	Adipose	Stem	Cells),	PCL	(poly-ε-caprolactone),	PLA	(Poly(lactic	acid)),	PVA	(Poly(vinyl	alcohol),	RGD-GG	(GG	
modified	with	the	peptide	G4RGDSY),	UV	(Ultra	Violet)	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Examples	of	Engineered	Tissues	using	GG	
As	GG	materials	design	and	processing	 technologies	 continue	
to	 mature,	 research	 interest	 is	 progressing	 towards	 the	
application	 of	 GG	 in	 biofabrication,	 tissue	 engineering	 and	
regenerative	 medicine.	 To	 conclude	 this	 review,	 we	 will	
highlight	 several	works	 that	 exemplify	 the	 potential	 of	 GG	 in	
tissue	 engineering,	 including	 the	 creation	 of	 implants,	 tissue	
mimics	and	cell	arrays.	
	
Cartilage	repair	is	a	major	target	application	for	GG,	a	research	
area	that	has	been	pursued	intensively	by	the	Reis	group66,	126,	
143,	 144.	 In	 one	 report	 from	 2010,	 the	 group	 created	 several	
injectable	 formulations	of	GG	that	were	used	to	treat	defects	
in	 rabbit	 knee	 joints66.	 When	 these	 GG	 formulations	 were	
prepared	 as	 blends	 with	 growth	 factors	 and	 articular	
chondrocytes	or	adipose	stem	cells,	the	material	was	observed	
to	visibly	repair	the	knee	cartilage	over	a	period	of	8	weeks	 in	
vivo	 (Figure	 5A).	 In	 this	 case,	 Oliveira	 et	 al.	 applied	 a	
commercial	 GG	 material	 without	 further	 modifications,	
however	 several	 other	 works	 have	 employed	 blended	 or	
modified	 GGs	 for	 cartilage	 tissue	 engineering,	 particularly	
hyaluronic	acid	blends37,	87,	88,	117.	
	
A	 second	 example	 regards	 the	 ink-jet	 printing	 of	 cell	
microarrays	using	GG	microgel	bio-inks.	As	described	earlier	in	
this	 review,	 Ferris	 et	 al.	 developed	 GG	microgel	 suspensions	
that	 prevented	 cell	 settling	 and	 protected	 cells	 during	 ink-jet	
printing,	 factors	 that	 allowed	 for	 highly	 controlled	 delivery	
down	 to	 single	 cell	 resolution121.	 Ellis	 et	 al.	 utilized	 this	
Technique
Gelling 
Mechanism Materials Cell Processing
Target Tissue  
(Cell Type) Reference
Extrusion Printing
Photo	(UV)	
cross-linking	
GG	
Gela6n	methacrylate	
Encapsulated	in	
GG:GelMa	
Car6lage	
(Chondrocytes)	 Visser	2013	
Photo	(UV)	
cross-linking	
GG	
PLA	cell	carriers	
Gela6n	methacrylamide	
On	PLA		
microspheres	
Bone	
(Mesenchymal	
Stromal	Cells)	
Levarto	2014	
Reac6ve	Prin6ng	
(Ionic)	
GG	
CaCl2	
Encapsulated	in	
GG	 (Fibroblasts	L929)	 Stevens	2016	
Reac6ve	Prin6ng	
(Ionic)	
RGD-GG	
CaCl2	
Encapsulated	in	
GG	
Cortex	Mimic	
(Cor6cal	Neurons)	 Lozano	2015	
Inkjet Printing
Thermal	/	Ionic	
(Under	Shear)	
GG	
CaCl2	
Novec	FC-4430	
Poloxamer	
Individual	cell	
deposi6on	
Various	
(Fibroblast	L929)	
(Muscle	C2C12)	
(Nerve	PC12)	
Ferris	2013	
Ellis	2012	
Wet Spinning
Ionic	/	
Neutralisa6on	
Alkaline	GG	
Ascorbic	acid	 Unspecified	 Car6lage	 Oliveira	2010	
Complexa6on	
GG	
Chitosan	 Unspecified	 No	Cells	 Granero	2009	
Complexa6on	
GG	
Amyloid	protein	nanofibers	 Unspecified	 No	Cells	 Meier	2011	
Complexa6on	
GG	
Chitosan	 Unspecified	 No	Cells	 Amiake	1998	
Freeze Drying
Thermal	/	Ionic	
Lyophilized	
GG	
CaCl2	
Post	Seeding	
Car6lage		
(hASC)	 Da	Silva	2014	
Thermal	/	Ionic	
Lyophilized	
GG	
Hyaluronic	Acid	
CaCl2	
Implanta6on	
Skin	Repair	/	
Vascularisa6on	 Cerqueira	2014	
Lyophilized	
Covalent	Linkage	
GG	
EDC	 Implanta6on	 Dental	Filling	 Chang	2012	
Electrospinning
Solvent	
Evapora6on	 GG:PVA	(50:50)	 Post	Seeding	 Unspecified	 Vashisth	2014	
Reac6ve	Air	
Brushing	(Ionic)	
GG	
CaCl2	
PCL	
Post	Seeding	 nucleus	pulposus		 Thorvaldsson	2013	
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approach	to	 ink-jet	print	single-cell	microarrays	of	L929,	PC12	
and	 C2C12	 cell	 lines	 (Figure	 5B),	 and	 then	 probed	 the	
molecular	 profiles	 of	 individual	 cells	 using	 a	 combination	 of	
liquid	 micro-extraction	 and	 nano-electrospray	 mass	
spectrometry	 techniques127.	 The	 authors	 conducted	 lipid	
profiling	 that	 positively	 identified	 cells	 through	 their	 lipid	
‘finger	print’,	 allowing	a	 conclusive	 identification	of	 the	 three	
tested	cell	types.	However	the	technique’s	true	value	likely	lies	
in	 its	 potential	 for	 furthering	 the	 fundamental	 understanding	
of	 cell	 behaviours	 through	 single	 cell	 testing,	 providing	 a	
valuable	 alternative	 to	 the	 multi-cellular	 assays	 and	 PCR	
techniques	applied	routinely	in	cell	biology.		
	
More	 recently,	 the	 chemically	 modified	 GG’s	 have	 been	
applied	 in	 tissue	engineering	 contexts.	 Lozano	et	al.	 reported	
on	the	formation	of	a	multi-layered	proto-tissue	reflecting	the	
structure	 of	 the	 cortex	 (Figure	 5C)38.	 The	 work	 utilised	 a	
peptide	modified	 GG	material	 initially	 developed	 by	 Ferris	 et	
al.51,	 which	 Lozano	 further	 demonstrated	 to	 be	 highly	
supportive	of	primary	neural	cell	differentiation.	In	addition	to	
peptide-modification,	 the	cortical	mimic	was	 formed	with	 the	
aid	 of	 a	 novel	 reactive	 extrusion	 system	 that	 allowed	 for	 the	
simultaneous	 and	 hand-controlled	 delivery	 of	 RGD-GG,	 CaCl2	
and	 cortical	 neurons	 in	 a	 spatially	 controlled	manner.	Whilst	
not	 intended	for	regenerative	medicine,	the	authors	reported	
these	 cortical	 proto-tissues	 to	 have	 potential	 as	 an	 in	 vitro	
model	of	brain	tissue	function	and	development,	which	could	
conceivably	 be	 applied	 for	 fundamental	 studies	 on	 a	 wide	
range	of	neurological	processes	and	disorders.		
	
Jamshidi	et	al.	 have	 recently	 reported	another	GG	derivative,	
formed	 by	 blending	 GG	 and	 nano-hydroxyapatite,	 as	 an	
excellent	substrate	for	regenerating	bone	tissue	(Figure	5D)80.	
Their	 structures	were	 reported	 to	 lead	 to	 significant	 rates	 of	
osteogenesis,	 and	 stimulated	 osteogenic	 differentiation	 of	
bone	marrow	stromal	cells	even	 in	the	absence	of	osteogenic	
media.	This	work	compliments	several	other	reports	that	have	
shown	 the	 potential	 of	 GG	 for	 bone	 tissue	 engineering	 and	
regeneration	 with	 alternative	 blending	 materials	 including	
hyaluronic	 acid34,	 gelatin	 82	 and	 gold	 nanorods81,	 and	 GG	
blending	 appears	 to	provide	 a	promising	 route	 towards	bone	
tissue	engineering		
	
The	above	examples	have	been	selected	to	represent	the	use	
of	GG	across	a	variety	of	different	tissue	types	and	application	
pathways,	however	these	examples	are	not	exhaustive.	Gellan	
gum	 and	 its	 derivatives	 have	 also	 been	 applied	 for	 adipose	
stem	cell	culture73,	angiogenesis	and	vasculature	promotion68,	
72,	 anti-adhesion	 and	 wound	 healing107,	 108,	 114	 and	 drug	
release114,	145,	146.	The	versatility	of	GG	to	perform	across	each	
of	 these	 roles	 is	 a	major	 rationale	 for	 its	ongoing	exploration	
and	development.	It	is	hoped	that	further	study	will	reveal	yet	
more	applications	for	this	versatile	polysaccharide.			
	
	
Figure	 5:	 Examples	 of	 the	 use	 of	 GG	 in	 implantation,	 bioprinting	 and	 tissue	
engineering.	(A)	The	repair	of	rabbit	cartilage	with	injectable	GG	hydrogels	laden	with	
predifferentiated	adipose	 stem	cells	 (ASC),	 articular	 chondrocytes	 (AC)	or	 as	 acellular	
controls	(GG),	reported	by	Oliveria	et	al.66.	(B)	The	inkjet	bioprinting	of	muscle	(C2C12)	
and	nerve	(PC12)	modelling	cell	lines	using	a	GG	microgel	bioink	developed	by	Ferris	et	
al.121	and	applied	for	single	cell	 lipidomics	by	Ellis	et	al.127.	 (C)	A	multi-layered	cortical	
tissue	 mimic	 formed	 by	 the	 reactive	 printing	 of	 RGD-modified	 GG	 and	 CaCl2	 with	
encapsulated	 primary	mouse	 cortex38.	 (D)	 A	 bone	 proto-tissue	 formed	 by	MC3T3-E1	
cells	 grown	 on	 the	 surface	 of	 GG/nano-hydroxyapatite	 composites80.	 Copyright	
material	reproduced	with	permissions	from	John	Wiley	&	Sons	(A,D),	Royal	Society	of	
Chemistry	(B)	and	Elsevier	(C).		
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Conclusions	and	Future	Directions	
This	 review	 has	 sought	 to	 inform	 readers	 about	 the	
polysaccharide	 gellan	 gum,	 and	 in	 particular	 its	 emerging	
potential	 as	 a	 biomaterial	 for	 tissue	 engineering.	On	 its	 own,	
gellan	 gum	 provides	 a	 readily	 synthesised,	 purified	 and	
processed	 biopolymer	 able	 to	 encapsulate	 mammalian	 cells	
with	minimal	cytotoxicity.	However,	the	most	promising	aspect	
of	 gellan	 gum	 is	 its	 extensive	 capacity	 for	 modification	 and	
optimisation	 to	 suit	 particular	 applications.	 As	 part	 of	 this	
review	 we	 have	 documented	 the	 reported	 pathways	 for	
tailoring	 the	 biological,	 mechanical,	 electrical	 and	 physical	
properties	 of	 GG,	 including	 chemical	 modifications,	 physical	
modifications,	 blending	 and	 controlled	 processing.	 Following	
these	 modifications,	 GG	 has	 been	 shown	 to	 be	 a	 viable	
substrate	 for	 the	 engineering	 of	 tissues	 as	 diverse	 as	 bone,	
cartilage,	 muscle	 and	 brain,	 and	 has	 additionally	 been	
employed	 for	 drug	 delivery,	 anti-fouling,	 soft	 conductors	 and	
stem	 cell	 culture.	 This	 versatility	 provides	 a	 rationale	 for	
furthering	 GG	 research,	 and	 it	 is	 anticipated	 that	 many	
avenues	of	application	for	the	material	are	yet	to	be	explored.	
Based	 on	 the	 literature	 reviewed	 here,	 we	 make	 several	
recommendations	 for	 extending	 GG	 research	 towards	 the	
fabrication	of	complex	engineered	tissues.	
	
Recommendation	 1	 –	 Purify	 gellan	 gum	 to	 a	monovalent	 salt	
forms	 prior	 to	 use.	 Purification	 of	 divalent	 cations	 has	 been	
shown	 to	 significantly	 improve	 the	 solubility,	 processability	
and	 modification	 potential	 of	 the	 material	 over	 commercial	
grades	of	GG.		
	
Recommendation	 2	 –	 Apply	 relevant	 modification	 and	
blending	processes	of	GG	to	improve	strength,	biofunctionality	
and	cross-linking	behaviours.	Required	modifications	will	differ	
between	 applications,	 however	 tissues	 scaffolds	 may	 benefit	
from	GG	methacrylation,	peptide	modification,	or	the	blending	
of	GG	with	hyaluronic	acid	or	gelatin.	
	
Recommendation	 3	 –	 Apply	 biofabrication	 machinery	 and	
processes	developed	for	alginate	for	the	processing	of	GG.	The	
processing	 behaviours	 and	 cross-linking	 mechanisms	 of	
alginate	and	GG	are	closely	related,	and	utilising	the	significant	
foundation	 laid	 by	 alginate	 research	 presents	 an	 efficient	
means	for	accelerating	the	progress	of	GG	biofabrication.	
	
Recommendation	4	–	Apply	sterilisation	procedures	cautiously.	
Heat-based	 sterilisation	 processes,	 notably	 autoclaving,	 are	
likely	to	reduce	the	molecular	weight	of	GG	chains	and	impact	
the	 mechanical,	 rheological	 and	 biological	 behaviours	 of	 GG	
hydrogels.	 Whilst	 such	 changes	 may	 be	 beneficial	 for	 many	
tissue	 applications,	 the	 impacts	 of	 sterilisation	 should	
nevertheless	be	considered.		
	
Recommendation	 5	 –	 Elucidate	 the	 biodegradation	 pathways	
of	GG	and	GG	hydrogels.	Research	focused	in	this	area	would	
provide	information	on	expected	lifetimes	of	GG	implants,	and	
be	beneficial	for	GG	tissue	engineering	as	a	whole.		
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